Page 6 - Section Head News Today

A wildlife park is working to bring four lions, abandoned when Russia invaded, to England.

Supira's technology features a novel low profile, high continuous flow design that aims to provide full hemodynamic support for high-risk percutaneous coronary interventions (HRPCI) and cardiogenic shock (CS) patients with a single device

/PRNewswire/ -- Supira Medical, Inc., a Shifamed portfolio company, announced today that the companys percutaneous ventricular assist device (pVAD) will be...

Doha, Qatar: Qatar University (QU) recently unveiled a range of pioneering research projects at the 18th Engineering Forum of Qatar Energy LNG, held a...

Blackpool Zoo has officially named its critically endangered baby orangutan after an online competition saw the attraction smash its fundraising…

/PRNewswire/ -- Women-led discussions and research on climate change were more prominent than ever during the 78th UN General Assembly and Climate Week NYC, as...

ELI-002 2P is an investigational therapeutic cancer vaccine targeting solid tumors driven by G12D and G12R mutations in KRASAs of the April 25, 2023 data cut-off date, among the 22 evaluable patients,...

/PRNewswire/ -- University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today that Shawn Kwatra, MD will become the next Chair of...

Backing its efforts to improve the quality of services provided to investors and promote investment opportunities in the affiliated zones

RADNOR, Pa.--(BUSINESS WIRE)--$MRNS #MarinusPharma--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the speakers for its upcoming Investor & Analyst Event on Tuesday, September 19 from 9:00 a.m....